Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling
Authors:
- Steven N. MinkSMSteven N. Mink
- Zhao-Qin ChengZCZhao-Qin Cheng
- Ratna BoseRBRatna Bose
- Hans JacobsHJHans Jacobs
- Krika KasianKKKrika Kasian
- Diane E. RobertsDRDiane E. Roberts
- Luis E. Santos-MartinezLSLuis E. Santos-Martinez
- R. Bruce LightRLR. Bruce Light
- 1 November 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 293 (5) , H3140-H3149
Abstract
We previously showed that lysozyme (Lzm-S), derived from leukocytes, caused myocardial depression in canine sepsis by binding to the endocardial endothelium to release nitric oxide (NO). NO then diffuses to adjacent myocytes to activate the cGMP pathway. In a canine right ventricular trabecular (RVT) preparation, Lzm-S also decreased the inotropic response to field stimulation (FSR) during which the sympathetic and parasympathetic nerves were simulated to measure the adrenergic response. In the present study, we determined whether the pathway by which Lzm-S decreased FSR was different from the pathway by which Lzm-S reduced steady-state (SS) contraction. Furthermore, we determined whether the decrease in FSR was due to a decrease in sympathetic stimulation or enhanced parasympathetic signaling. In the RVT preparation, we found that the inhibitory effect of Lzm-S on FSR was prevented by NO synthase (NOS) inhibitors. A cGMP inhibitor also blocked the depressant activity of Lzm-S. However, in contrast to the Lzm-S-induced decline in SS contraction, chemical removal of the endocardial endothelium by Triton X-100 to eliminate endothelial NO release did not prevent the decrease in FSR. An inhibitory G protein was involved in the effect of Lzm-S, since FSR could be restored by treatment with pertussis toxin. Atropine prevented the Lzm-S-induced decline in FSR, whereas β1- and β2-adrenoceptor function was not impaired by Lzm-S. These results indicate that the Lzm-S-induced decrease in FSR results from a nonendothelial release of NO. NO then acts through inhibitory G protein to enhance parasympathetic signaling.Keywords
This publication has 35 references indexed in Scilit:
- Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3′,5′ monophosphate pathway in sepsisJournal of Molecular and Cellular Cardiology, 2005
- Cardiac nitric oxide: Emerging role for nNOS in regulating physiological functionPharmacology & Therapeutics, 2005
- Septic shockThe Lancet, 2005
- Nitric oxide-cGMP pathway is involved in endotoxin-induced contractile dysfunction in rat heartsJournal of Applied Physiology, 2004
- N,N′,N′-triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in Escherichia coli sepsis in dogs*Critical Care Medicine, 2004
- Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig in vitroThe Journal of Physiology, 2001
- An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shockCritical Care Medicine, 1999
- Role of the Endocardial Endothelium in the Negative Inotropic Effects of ThiopentalAnesthesiology, 1996
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- The measurement of lysozyme activity and the ultra-violet inactivation of lysozymeBiochimica et Biophysica Acta, 1952